Technical Analysis for DSGN - Design Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 2.52 | -2.33% | -0.06 |
DSGN closed down 2.33 percent on Monday, March 18, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 19
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Crossed Above 50 DMA | Bullish | -2.33% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -2.33% | |
Pocket Pivot | Bullish Swing Setup | -2.33% | |
Inside Day | Range Contraction | -2.33% | |
Lower Bollinger Band Touch | Weakness | -2.33% | |
Oversold Stochastic | Weakness | -2.33% |
Alert | Time |
---|---|
Lower Bollinger Band Support | about 12 hours ago |
Down 5% | about 13 hours ago |
Fell Below Previous Day's Low | about 13 hours ago |
Gap Up Closed | about 13 hours ago |
Gap Up Partially Closed | about 13 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/19/2024
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 8.47 |
52 Week Low | 1.94 |
Average Volume | 198,275 |
200-Day Moving Average | 3.46 |
50-Day Moving Average | 2.55 |
20-Day Moving Average | 2.77 |
10-Day Moving Average | 2.73 |
Average True Range | 0.15 |
RSI (14) | 43.18 |
ADX | 28.82 |
+DI | 12.34 |
-DI | 21.30 |
Chandelier Exit (Long, 3 ATRs) | 2.53 |
Chandelier Exit (Short, 3 ATRs) | 2.78 |
Upper Bollinger Bands | 3.03 |
Lower Bollinger Band | 2.51 |
Percent B (%b) | 0.03 |
BandWidth | 18.93 |
MACD Line | 0.01 |
MACD Signal Line | 0.06 |
MACD Histogram | -0.0507 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.79 | ||||
Resistance 3 (R3) | 2.80 | 2.71 | 2.74 | ||
Resistance 2 (R2) | 2.71 | 2.64 | 2.71 | 2.73 | |
Resistance 1 (R1) | 2.62 | 2.60 | 2.58 | 2.61 | 2.71 |
Pivot Point | 2.53 | 2.53 | 2.51 | 2.53 | 2.53 |
Support 1 (S1) | 2.44 | 2.46 | 2.40 | 2.43 | 2.33 |
Support 2 (S2) | 2.35 | 2.42 | 2.35 | 2.31 | |
Support 3 (S3) | 2.26 | 2.35 | 2.30 | ||
Support 4 (S4) | 2.25 |